FIELD: chemistry, medicine.
SUBSTANCE: novel antibodies and fragments of human antibodies are bound with GDF-8 in a specific way and inhibit its activity in vitro and/or in vivo. On the basis of said invention pharmaceutical composition is created, which can be used for diagnostics, prevention or treatment of degenerative dysfunctions of muscle or bone or disorders of insulin metabolism.
EFFECT: extending range of arsenal of technical means used in treatment of diseases related to muscular, bone tissue or insulin metabolism.
| Title | Year | Author | Number |
|---|---|---|---|
| IMPROVED ANTIBODIES GDF-8 ANTAGONISTS AND THEIR USE | 2013 |
|
RU2630634C2 |
| ANTIBODIES AGAINST HUMAN GDF8 | 2011 |
|
RU2567805C2 |
| GDF8 HUMAN ANTIBODIES | 2011 |
|
RU2710156C2 |
| APPLYING MYOSTATIC INHIBITORS (GDF8) IN COMBINATION WITH CORTICOSTEROIDS FOR TREATING NERVOUS-MUSCULAR DISEASES | 2004 |
|
RU2322261C2 |
| IL-6 ANTAGONISTS AND USES THEREOF | 2013 |
|
RU2670943C9 |
| ANTIBODIES AGAINST PD-1 AND THEIR USE | 2018 |
|
RU2788616C2 |
| NEUTRALIZING BINDING MOLECULES DIRECTED AGAINST INFLUENZA VIRUS, AND METHODS OF THEIR APPLICATION | 2016 |
|
RU2721706C2 |
| PARTNERS OF SPECIFIC BINDING WITH NGF | 2006 |
|
RU2406728C2 |
| HUMAN IL-13 ANTIBODY MOLECULES | 2004 |
|
RU2387667C2 |
| MOLECULES WHICH BIND TO PSL PSEUDOMONAS, AND METHODS FOR USE THEREOF | 2012 |
|
RU2708977C2 |
